The developmental pattern of the RAS/RAF/Erk1/2 pathway in the BTBR autism mouse model

International Journal of Developmental Neuroscience

Volumn 39, Issue C, 2014, Pages 2-8

  Yin, Ailan ^a,b   Qiu, Yuwen ^a   jia, Bei ^a   Song, Tianrong ^a   Yu, Yanhong ^b   Alberts, Ian ^c   Zhong, Mei ^a  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c Department of Mathematics Engineering and Computer Science   (United States)

Author keywords

Autism; Autism mouse model; BTBR mice; Ras Raf Erk 1 2 signaling; Synapse

Indexed keywords

ANIMAL; AUTISM; COMPLICATION; DEVELOPMENTAL DISABILITIES; DISEASE MODEL; GENETICS; HUMAN; MOUSE; PHYSIOLOGY; RETRACTED ARTICLE; SIGNAL TRANSDUCTION;

ANIMALS; AUTISTIC DISORDER; DEVELOPMENTAL DISABILITIES; DISEASE MODELS, ANIMAL; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE;

EID: 84930726721     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2014.01.006     Document Type: Article

References (65)

1. Murphy L.O., Blenis J. MAPK signal specificity: the right place at the right time. Trends Biochem. Sci. 2006, 31:268-275.
2. Subramaniam S., Unsicker K. ERK and cell death: ERK1/2 in neuronal death. FEBS J. 2010, 277:22-29.
3. Davis S., Laroche S. Mitogen-activated protein kinase/extracellular regulated kinase signalling and memory stabilization: a review. Genes Brain Behav. 2006, 5:61-72.
4. Stanciu M., Wang Y., Kentor R., Burke N., Watkins S., Kress G., Reynolds I., Klann E., Angiolieri M.R., Johnson J.W., DeFranco D.B. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 2000, 275:12200-12206.
5. Lesuisse C., Martin L.J. Immature and mature cortical neurons engage different apoptotic mechanisms involving caspase-3 and the mitogen-activated protein kinase pathway. J. Cereb. Blood Flow Metab. 2002, 22:935-950.
6. Lu K.T., Cheng N.C., Wu C.Y., Yang Y.L. NKCC1-mediated traumatic brain injury-induced brain edema and neuron death via Raf/MEK/MAPK cascade. Crit. Care Med. 2008, 36:917-922.
7. Chen X., Lan X., Mo S., Qin J., Li W., Liu P., Han Y., Pi R. p38 and ERK, but not JNK are involved in copper-induced apoptosis in cultured cerebellar granule neurons. Biochem. Biophys. Res. Commun. 2009, 379:944-948. (PubMed, 19138669).
8. Sheikh A.M., Li X., Wen G., Tauqeer Z., Brown W.T., Malik M. Cathepsin D and apoptosis related proteins are elevated in the brain of autistic subjects. Neuroscience 2010, 165:363-370.
9. Sheikh A.M., Malik M., Wen G., Chauhan A., Chauhan V., Gong C.X., Liu F., Brown W.T., Li X. BDNF-Akt-Bcl2 anti-apoptotic signaling pathway is compromised in the brain of autistic subjects. J. Neurosci. Res. 2010, 88:2641-2647.
10. Araghi-Niknam M., Fatemi S.H. Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects. Cell. Mol. Neurobiol. 2003, 23:945-952.
11. Fatemi S.H., Halt A.R. Altered levels of Bcl-2 and P53 proteins in parietal cortex reflect deranged apoptotic regulation in autism. Synapse 2001, 15:281-284.
12. Fatemi S.H., Halt A.R., Stary J.M., Realmuto G.M., Jalali-Mousavi M. Reduction in anti-apoptotic protein Bcl2 in autistic cerebellum. Neuroreport 2001, 12:929-933.
13. Kumar R.A., KaraMohamed S., Sudi J., Conrad D.F., Brune C., Badner J.A., Gilliam T.C., Nowak N.J., Cook E.H., Dobyns W.B., Christian S.L. Recurrent 16p11.2 microdeletions in autism. Hum. Mol. Genet. 2008, 17:628-638.
14. Weiss L.A., Shen Y., Korn J.M., Arking D.E., Miller D.T., Fossdal R., Saemundsen E., Stefansson H., Ferreira M.A., Green T., Platt O.S., Ruderfer D.M., Walsh C.A., Altshuler D., Chakravarti A., Tanzi R.E., Stefansson K., Santangelo S.L., Gusella J.F., Sklar P., Wu B.L., Daly M.J. Autism consortium. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 2008, 358:667-675.
15. Bolivar V.J., Walters S.R., Phoenix J.L. Assessing autism-like behavior in mice, variations in social interactions among inbred strains. Behav. Brain Res. 2007, 176:21-26.
16. Moy S.S., Nadler J.J., Young N.B., Perez A., Holloway L.P., Barbaro R.P., Barbaro J.R., Wilson L.M., Threadgill D.W., Lauder J.M., Magnuson T.R., Crawley J.N. Mouse behavioral tasks relevant to autism, phenotypes of 10 inbred strains. Behav. Brain Res. 2007, 176:4-20.
17. + tf/J mice. Genes Brain Behav. 2008, 7:52-63.
18. Silverman J.L., Tolu S.S., Barkan C.L., Crawley J.N. Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology 2010, 35:976-989.
19. Scattoni M.L., Crawley J., Ricceri L. Ultrasonic vocalizations, A tool for behavioural phenotyping of mouse models of neurodevelopmental disorders. Neurosci. Biobehav. Rev. 2009, 33:508-515.
20. + tf/J, C57BL/6J, and vasopressin receptor 1B mutant mice. Front. Behav. Neurosci. 2007, 1:1.
21. + tf/J mice are unchanged by cross-fostering with C57BL/6J mothers. Int. J. Dev. Neurosci. 2007, 25:515-521.
22. Scattoni M.L., Crawley J., Ricceri L. Ultrasonic vocalizations, a tool for behavioural phenotyping of mouse models of neurodevelopmental disorders. Neurosci. Biobehav. Rev. 2009, 33:508-515.
23. Courchesne E., Campbell K., Solso S. Brain growth across the life span in autism, age-specific changes in anatomical pathology. Brain Res. 2011, 1380:138-145.
24. Vidal C.N., Nicolson R., Boire J.-Y., Barra V., DeVito T.J., Hayashi K.M. Three dimensional of the lateral ventricles in autism. Psychiatry Res. 2008, 163:106-115.
25. Wegiel J., Kuchna I., Nowicki K., Imaki H., Wegiel J., Marchi E., Ma S.Y., Chauhan A., Chauhan V., Bobrowicz T.W., de Leon M., Louis L.A., Cohen I.L., London E., Brown W.T., Wisniewski T. The neuropathology of autism, defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol. 2010, 119:755-770.
26. Ecker C., Suckling J., Deoni S.C., Lombardo M.V., Bullmore E.T., Baron-Cohen S., Catani M., Jezzard P., Barnes A., Bailey A.J., Williams S.C., Murphy D.G. Brain anatomy and its relationship to behavior in adults with autism spectrumdisorder,a multicenter magnetic resonance imaging study. Arch. Gen. Psychiatry 2012, 69:195-209. MRC AIMS Consortium.
27. + tf/J mouse model of autism. PLoS One 2013, 8:e61829.
28. Kalkman H.O. Potential opposite roles of the extracellular signal-regulated kinase (ERK) pathway in autism spectrum and bipolar disorders. Neurosci. Biobehav. Rev. 2012, 36:2206-2213.
29. Mazzucchelli C., Vantaggiato C., Ciamei A., Fasano S., Pakhotin P., Krezel W., Welzl H., Wolfer D.P., Pagès G., Valverde O., Marowsky A., Porrazzo A., Orban P.C., Maldonado R., Ehrengruber M.U., Cestari V., Lipp H.P., Chapman P.F., Pouysségur J., Brambilla R. Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 2002, 34:807-820.
30. Satoh Y., Endo S., Ikeda T., Yamada K., Ito M., Kuroki M., Hiramoto T., Imamura O., Kobayash Y., Watanabe Y., Itohara S., Takishima K. Extracellular signal-regulated kinase 2 (ERK2) knockdown mice show deficits in long-term memory; ERK2 has a specific function in learning and memory. J. Neurosci. 2007, 27:10765-11076.
31. Satoh Y., Kobayashi Y., Takeuchi A., Pagès G., Pouysségur J., Kazama T. Deletion of ERK1 and ERK2 in the CNS causes cortical abnormalities and neonatal lethality, Erk1 deficiency enhances the impairment of neurogenesis in Erk2-deficient mice. J. Neurosci. 2011, 31:1149-1155.
32. Shalin S.C., Zirrgiebel U., Honsa K.J., Julien J.P., Miller F.D., Kaplan D.R., Sweatt J.D. Neuronal Mek is important for normal fear conditioning in mice. J. Neurosci. Res. 2004, 75:760-770.
33. Zoghbi H.Y. Postnatal neurodevelopmental disorders, meeting at the synapse?. Science 2003, 302:826-830.
34. Belmonte M.K., Bourgeron T. Fragile X syndrome and autism at the intersection of genetic and neural networks. Nat. Neurosci. 2006, 9:1221-1225.
35. Durand C.M., Betancur C., Boeckers T.M., Bockmann J., Chaste P., Fauchereau F., Nygren G., Rastam M., Gillberg I.C., Anckarsäter H., Sponheim E., Goubran-Botros H., Delorme R., Chabane N., Mouren-Simeoni M.C., de Mas P., Bieth E., Rogé B., Héron D., Burglen L., Gillberg C., Leboyer M., Bourgeron T. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 2007, 39:25-27.
36. Kim H.G., Kishikawa S., Higgins A.W., Seong I.S., Donovan D.J., Shen Y., Lally E., Weiss L.A., Najm J., Kutsche K., Descartes M., Holt L., Braddock S., Troxell R., Kaplan L., Volkmar F., Klin A., Tsatsanis K., Harris D.J., Noens I., Pauls D.L., Daly M.J., MacDonald M.E., Morton C.C., Quade B.J., Gusella J.F. Disruption of neurexin 1 associated with autism spectrum disorder. Am. J. Hum. Genet. 2008, 82:199-207.
37. Bakkaloglu B., O'Roak B.J., Louvi A., Gupta A.R., Abelson J.F., Morgan T.M., Chawarska K., Klin A., Ercan-Sencicek A.G., Stillman A.A., Tanriover G., Abrahams B.S., Duvall J.A., Robbins E.M., Geschwind D.H., Biederer T., Gunel M., Lifton R.P., State M.W. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am. J. Hum. Genet. 2008, 82:165-173.
38. Alarcón M., Abrahams B.S., Stone J.L., Duvall J.A., Perederiy J.V., Bomar J.M., Sebat J., Wigler M., Martin C.L., Ledbetter D.H., Nelson S.F., Cantor R.M., Geschwind D.H. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am. J. Hum. Genet. 2008, 82:150-159.
39. Arking D.E., Cutler D.J., Brune C.W., Teslovich T.M., West K., Ikeda M., Rea A., Guy M., Lin S., Cook E.H., Chakravarti A. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am. J. Hum. Genet. 2008, 82:160-164.
40. Marshall C.R., Noor A., Vincent J.B., Lionel A.C., Feuk L., Skaug J., Shago M., Moessner R., Pinto D., Ren Y., Thiruvahindrapduram B., Fiebig A., Schreiber S., Friedman J., Ketelaars C.E., Vos Y.J., Ficicioglu C., Kirkpatrick S., Nicolson R., Sloman L., Summers A., Gibbons C.A., Teebi A., Chitayat D., Weksberg R., Thompson A., Vardy C., Crosbie V., Luscombe S., Baatjes R., Zwaigenbaum L., Roberts W., Fernandez B., Szatmari P., Scherer S.W. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 2008, 82:477-488.
41. Morrow E.M., Yoo S.Y., Flavell S.W., Kim T.K., Lin Y., Hill R.S., Mukaddes N.M., Balkhy S., Gascon G., Hashmi A., Al-Saad S., Ware J., Joseph R.M., Greenblatt R., Gleason D., Ertelt J.A., Apse K.A., Bodell A., Partlow J.N., Barry B., Yao H., Markianos K., Ferland R.J., Greenberg M.E., Walsh C.A. Identifying autism loci and genes by tracing recent shared ancestry. Science 2008, 321:218-223.
42. Fujita E., Tanabe Y., Imhof B.A., Momoi M.Y., Momoi T. Cadm1-expressing synapses on Purkinje cell dendrites are involved in mouse ultrasonic vocalization activity. PLoS One 2012, 7:e30151.
43. Koike H., Arguello P.A., Kvajo M., Karayiorgou M., Gogos J.A. Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. PNAS 2006, 103:3693-3697.
44. Sgambato V., Pagès C., Rogard M., Besson M.J., Caboche J. Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation. J. Neurosci. 1998, 18:8814-8825.
45. Thomas G.M., Huganir R.L. MAPK cascade signalling and synaptic plasticity. Nat. Rev. Neurosci. 2004, 5:173-183.
46. Tada T., Sheng M. Molecular mechanisms of dendritic spine morphogenesis. Curr. Opin. Neurobiol. 2006, 16:95-101.
47. Gu Y., Stornetta R.L. Synaptic plasticity., AMPA-R trafficking., and Ras-MAPK signaling. Acta Pharmacol. Sin. 2007, 28:928-936.
48. Adams J.P., Sweatt J.D. Molecular psychology, roles for the ERK MAP kinase cascade in memory. Annu. Rev. Pharmacol. Toxicol. 2002, 42:135-163.
49. Mazzucchelli C., Brambilla R. Ras-related and MAPK signalling in neuronal plasticity and memory formation. Cell. Mol. Life Sci. 2000, 57:604-611.
50. Peng F., Yao H., Bai X., Zhu X., Reiner B.C., Beazely M., Funa K., Xiong H., Buch S. Platelet-derived growth factor-mediated induction of the synaptic plasticity gene Arc/Arg3.1. J. Biol. Chem. 2010, 85:21615-21624.
51. Huang F., Chotiner J.K., Steward O. Actin polymerization and ERK phosphorylation are required for Arc/Arg3.1 mRNA targeting to activated synaptic sites on dendrites. J. Neurosci. 2010, 27:9054-9067.
52. Longuet C., Broca C., Costes S., Hani E.H., Bataille D., Dalle S. Extracellularly regulated kinases 1/2 (p44/42 mitogen-activated protein kinases) phosphorylate synapsin I and regulate insulin secretion in the MIN6 beta-cell line and islets of Langerhans. Endocrinology 2005, 146:643-654.
53. Beaudoin G.M., Schofield C.M., Nuwal T., Zang K., Ullian E.M., Huang B., Reichardt L.F. Afadin, a Ras/Rap effector that controls cadherin function,promotes spine and excitatory synapse density in the hippocampus. J. Neurosci. 2012, 32:99-110.
54. Biou V., Brinkhaus H., Malenka R.C., Matus A. Interactions between drebrin and Ras regulate dendritic spine plasticity. Eur. J. Neurosci. 2008, 27:2847-2859.
55. Goffin A., Hoefsloot L.H., Bosgoed E., Swillen A., Fryns J.P. PTEN mutation in a family with Cowden syndrome and autism. Am. J. Med. Genet. 2001, 105:521-524.
56. Butler M.G., Dasouki M.J., Zhou X.P., Talebizadeh Z., Brown M., Takahashi T.N., Miles J.H., Wang C.H., Stratton R., Pilarski R., Eng C. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J. Med. Genet. 2005, 42:318-321.
57. Campbell D.B., Sutcliffe J.S., Ebert P.J., Militerni R., Bravaccio C., Trillo S., Elia M., Schneider C., Melmed R., Sacco R., Persico A.M., Levitt P. A genetic variant that disrupts MET transcription is associated with autism. PNAS 2006, 103:16834-16839.
58. Durand C.M., Betancur C., Boeckers T.M., Bockmann J., Chaste P., Fauchereau F., Nygren G., Rastam M., Gillberg I.C., Anckarsäter H., Sponheim E., Goubran-Botros H., Delorme R., Chabane N., Mouren-Simeoni M.C., de Mas P., Bieth E., Rogé B., Héron D., Burglen L., Gillberg C., Leboyer M., Bourgeron T. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 2007, 39:25-27.
59. McKay M.M., Morrison D.K. Integrating signals from RTKs to ERK/MAPK. Oncogene 2007, 26:3113-3121.
60. Chalhoub N., Zhu G., Zhu X., Baker S.J. Cell type specificity of PI3K signaling in Pdk1- and Pten-deficient brains. Genes Dev. 2009, 23:1619-1624.
61. Levitt P., Campbell D.B. The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. J. Clin. Invest. 2009, 119:747-754.
62. Yang G., Gan W.B. Sleep contributes to dendritic spine formation and elimination in the developing mouse somatosensory cortex. Dev. Neurobiol. 2012, 72:1391-1398.
63. Froemke R.C., Jones B.J. Development of auditory cortical synaptic receptive fields. Neurosci. Biobehav. Rev. 2011, 35:2105-2113.
64. Mogha A., Guariglia S.R., Debata P.R., Wen G.Y., Banerjee P. Serotonin 1A receptor-mediated signaling through ERK and PKCα is essential for normal synaptogenesis in neonatal mouse hippocampus. Transl. Psychiatry 2012, 2:e66.
65. Elkobi A., Ehrlich I., Belelovsky K., Barki-Harrington L., Rosenblum K. ERK-dependent PSD-95 induction in the gustatory cortex is necessary for taste learning, but not retrieval. Nat. Neurosci. 2008, 11:1149-1151.